Effects of chelation therapy on cardiac function improvement in thalassemia patients: literature review and the Taiwanese experience. (Q37084714)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18274983%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

review article

1 reference

title

Effects of chelation therapy on cardiac function improvement in thalassemia patients: literature review and the Taiwanese experience (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18274983%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

0 references

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18274983%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

author name string

Ching-Tien Peng

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18274983%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

Chang-Hai Tsai

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18274983%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

publication date

1 January 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18274983%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18274983%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

volume

32

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18274983%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

issue

1-2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18274983%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

page(s)

49-62

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18274983%20AND%20SRC:MED&resulttype=core&format=json

Tricuspid regurgitation in patients with beta-thalassemia major

2 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1080%2F03630260701680078

Multislice multiecho T2* cardiovascular magnetic resonance for detection of the heterogeneous distribution of myocardial iron overload.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03630260701680078

Real-time myocardial contrast dobutamine stress echocardiography in coronary stenosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03630260701680078

Cardiac status in well-treated patients with thalassemia major

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03630260701680078

Long-term trial with the oral iron chelator 1, 2-dimethyl-3-hydroxypyrid-4-one (L1). I. Iron chelation and metabolic studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03630260701680078

Long-term assessment of efficacy and safety of L1, an oral iron chelator, in transfusion dependent thalassaemia: Indian trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03630260701680078

Long-term safety and effectiveness of iron-chelation therapy with deferiprone for thalassemia major

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03630260701680078

Comparison of effects of oral deferiprone and subcutaneous desferrioxamine on myocardial iron concentrations and ventricular function in beta-thalassaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03630260701680078

Randomized controlled trial of deferiprone or deferoxamine in beta-thalassemia major patients with asymptomatic myocardial siderosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03630260701680078

Cardiac morbidity and mortality in deferoxamine- or deferiprone-treated patients with thalassemia major

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03630260701680078

Results of long-term iron-chelating therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03630260701680078

Efficacy of deferoxamine in preventing complications of iron overload in patients with thalassemia major

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03630260701680078

Low serum ferritin levels are misleading for detecting cardiac iron overload and increase the risk of cardiomyopathy in thalassemia patients. The importance of cardiac iron overload monitoring using magnetic resonance imaging T2 and T2*.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03630260701680078

Safety monitoring of cardiac and hepatic systems in beta-thalassemia patients with chelating treatment in Taiwan

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03630260701680078

Combined therapy with deferiprone and desferrioxamine successfully regresses severe heart failure in patients with beta-thalassemia major

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03630260701680078

Iron absorption and loading in beta-thalassaemia intermedia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03630260701680078

Hepatic iron concentration and total body iron stores in thalassemia major.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03630260701680078

Value of sequential monitoring of left ventricular ejection fraction in the management of thalassemia major

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03630260701680078

Myocardial iron clearance during reversal of siderotic cardiomyopathy with intravenous desferrioxamine: a prospective study using T2* cardiovascular magnetic resonance

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03630260701680078

Deferiprone or deferoxamine vs. combination therapy in patients with beta-thalassemia major: a case study in Taiwan

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03630260701680078

21 January 2018

The beta-thalassemias

1 reference

https://api.crossref.org/works/10.1080%2F03630260701680078

The hypercoagulable state in thalassemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03630260701680078

Cardiac involvement in thalassemia intermedia: a multicenter study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03630260701680078

Pulmonary hypertension as a risk factor for death in patients with sickle cell disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03630260701680078